Metraipolis › archive › dc_35b02db5e8a7

Differential Effects of Inhibitory and Stimulatory Anti-HER2 Monoclonal Antibodies on AKT/ERK Signaling Pathways — Europe PMC PMID:30139234

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/30139234
DOI
10.22034/apjcp.2018.19.8.2255
License (as archived)
solo-consultazione
Archived
2026-11-05T15:37:41.427Z
SHA-256 of the archived text
1321615d5b8da0cad361285654a29613ee71f8e8678f9fe714c529ce9544cb98
Stable URL of this page
https://metraipolis.com/documento/dc_35b02db5e8a7

How to cite

Differential Effects of Inhibitory and Stimulatory Anti-HER2 Monoclonal Antibodies on AKT/ERK Signaling Pathways — Europe PMC PMID:30139234 — Europe PMC (en), https://europepmc.org/article/MED/30139234 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_35b02db5e8a7 (Metraipolis archive dc_35b02db5e8a7, sha256 1321615d5b8da0cad361285654a29613ee71f8e8678f9fe714c529ce9544cb98)
BibTeX
@misc{dc35b02db5e8a7,
  title = {Differential Effects of Inhibitory and Stimulatory Anti-HER2 Monoclonal Antibodies on AKT/ERK Signaling Pathways — Europe PMC PMID:30139234},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/30139234},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_35b02db5e8a7; sha256 1321615d5b8da0cad361285654a29613ee71f8e8678f9fe714c529ce9544cb98},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/30139234. Agents can read the archived copy with the MCP tool read_document.